Kraig Biocraft Laboratories Inc (KBLB)

[pj123]

Our ability to continue as a going concern is dependent upon our ability to raise additional capital and to ultimately achieve
sustainable revenues and profitable operations. At December 31, 2018, we had $13,697 of cash on hand
On March 9, 2019, Kraig Biocraft Laboratories, Inc. (the “Company”) entered into a purchase agreement with one investor (the “ Purchase Agreement ”). Pursuant to the Purchase Agreement, the Company issued the investor 14,797,278 Units at a purchase price of $0.06758 per Unit, for total gross proceeds to the Company of $1,000,000. The Units consist of 14,797,278 shares of the Company’s Class A Common Stock (the “ Common Stock ”) and two warrants (the “ Warrants ”): (i) one warrant entitles the investor to purchase up to 14,797,278 shares of Common Stock at an exercise price of $0.06 per share (the “ 6 Cent Warrants ”) and (ii) one warrant entitles the investor to purchase up to 7,398,639 shares of Common Stock at an exercise price of $0.08 per share (the “ 8 Cent Warrant ”). The Warrants shall be exercisable at any time from the issuance date until the following expiration dates:

Company now has 1,000,013,697 cash on hand.